179 related articles for article (PubMed ID: 38134862)
1. Arjunolic acid protects the intestinal epithelial barrier, ameliorating Crohn's disease-like colitis by restoring gut microbiota composition and inactivating TLR4 signalling.
Zhang Z; Zuo L; Song X; Wang L; Zhang Y; Cheng Y; Huang J; Zhao T; Yang Z; Zhang H; Li J; Zhang X; Geng Z; Wang Y; Ge S; Hu J
Phytomedicine; 2024 Jan; 123():155223. PubMed ID: 38134862
[TBL] [Abstract][Full Text] [Related]
2. Peiminine ameliorates Crohn's disease-like colitis by enhancing the function of the intestinal epithelial barrier through Nrf2/HO1 signal.
Qiu Q; Geng Z; Wang L; Zuo L; Deng M; Zhang H; Yang Y; Wang Y; Zhao Z; Wen H; Wang Q; Wang Y; He X; Li J; Wang Y; Zhang X; Liu M; Song X
Int Immunopharmacol; 2024 Jul; 136():112380. PubMed ID: 38850790
[TBL] [Abstract][Full Text] [Related]
3. Sotetsuflavone ameliorates Crohn's disease-like colitis by inhibiting M1 macrophage-induced intestinal barrier damage via JNK and MAPK signalling.
Ge S; Yang Y; Zuo L; Song X; Wen H; Geng Z; He Y; Xu Z; Wu H; Shen M; Ge Y; Sun X
Eur J Pharmacol; 2023 Feb; 940():175464. PubMed ID: 36566007
[TBL] [Abstract][Full Text] [Related]
4. Magnolin inhibits intestinal epithelial cell apoptosis alleviating Crohn's disease-like colitis by suppressing the PI3K/AKT signalling pathway.
Zhang M; Song X; Liu S; Zhang N; Yang M; Gao P; Geng Z; Zuo L; Zhang X; Wang L; Wang Y; Li J; Hu J
Int Immunopharmacol; 2024 Jun; 134():112181. PubMed ID: 38733829
[TBL] [Abstract][Full Text] [Related]
5. Sclareol protected against intestinal barrier dysfunction ameliorating Crohn's disease-like colitis via Nrf2/NF-B/MLCK signalling.
Wang L; Song X; Zhou Y; Xia Y; Yang Z; Chen X; Shi R; Geng Z; Zhang X; Wang Y; Li J; Hu J; Zuo L
Int Immunopharmacol; 2024 May; 133():112140. PubMed ID: 38669952
[TBL] [Abstract][Full Text] [Related]
6. Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis.
Qu Y; Li X; Xu F; Zhao S; Wu X; Wang Y; Xie J
Front Immunol; 2021; 12():679897. PubMed ID: 34367139
[TBL] [Abstract][Full Text] [Related]
7. Vindoline ameliorates intestinal barrier damage in Crohn's disease mice through MAPK signaling pathway.
Zhang X; Zuo L; Geng Z; Song X; Li J; Ge S; Jiang Y; Yang Z; Liu G; Zhao Y; Zhao H; Yu L; Hu J
FASEB J; 2022 Nov; 36(11):e22589. PubMed ID: 36197455
[TBL] [Abstract][Full Text] [Related]
8. Glycyrrhiza uralensis Fisch. alleviates dextran sulfate sodium-induced colitis in mice through inhibiting of NF-κB signaling pathways and modulating intestinal microbiota.
Shi G; Kong J; Wang Y; Xuan Z; Xu F
J Ethnopharmacol; 2022 Nov; 298():115640. PubMed ID: 36030029
[TBL] [Abstract][Full Text] [Related]
9. [Acetylcorynoline relieves 2, 4, 6-trinitrobenesulfonic acid-induced Crohn's disease-like colitis in mice by regulating intestinal epithelial cell apoptosis].
Li Q; Huang J; Sun Y; Xu Y; Wang L; Zhang X; Wang Y; Geng Z; Song X; Zuo L; Li J; Hu J
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Aug; 43(8):1306-1314. PubMed ID: 37712266
[TBL] [Abstract][Full Text] [Related]
10. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of RDP58 ameliorated DSS-induced colitis in intestinal microbiota dependent manner.
Zheng D; Ke X; Cai H; Yan C; Chen Y; Sun J; Chen G
Int Immunopharmacol; 2024 Jul; 136():112325. PubMed ID: 38820960
[TBL] [Abstract][Full Text] [Related]
12. Painong-San extract alleviates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota, restoring intestinal barrier function and attenuating TLR4/NF-κB signaling cascades.
Wang K; Guo J; Chang X; Gui S
J Pharm Biomed Anal; 2022 Feb; 209():114529. PubMed ID: 34915325
[TBL] [Abstract][Full Text] [Related]
13. [Pachymic acid protects against Crohn's disease-like intestinal barrier injury and colitis in miceby suppressingintestinal epithelial cell apoptosis
Shao R; Yang Z; Zhang W; Zhang N; Zhao Y; Zhang X; Zuo L; Ge S
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):935-942. PubMed ID: 37439165
[TBL] [Abstract][Full Text] [Related]
14. Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora.
Yan S; Chang J; Hao X; Liu J; Tan X; Geng Z; Wang Z
Phytomedicine; 2022 Jul; 102():154217. PubMed ID: 35660350
[TBL] [Abstract][Full Text] [Related]
15. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway.
Li C; Ai G; Wang Y; Lu Q; Luo C; Tan L; Lin G; Liu Y; Li Y; Zeng H; Chen J; Lin Z; Xian Y; Huang X; Xie J; Su Z
Pharmacol Res; 2020 Feb; 152():104603. PubMed ID: 31863867
[TBL] [Abstract][Full Text] [Related]
16. Qingchang Huashi Formula attenuates DSS-induced colitis in mice by restoring gut microbiota-metabolism homeostasis and goblet cell function.
Hu J; Huang H; Che Y; Ding C; Zhang L; Wang Y; Hao H; Shen H; Cao L
J Ethnopharmacol; 2021 Feb; 266():113394. PubMed ID: 32941971
[TBL] [Abstract][Full Text] [Related]
17. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota.
He X; Liu J; Long G; Xia XH; Liu M
Biomed Pharmacother; 2021 May; 137():111420. PubMed ID: 33761623
[TBL] [Abstract][Full Text] [Related]
18. Huangqin decoction ameliorates DSS-induced ulcerative colitis: Role of gut microbiota and amino acid metabolism, mTOR pathway and intestinal epithelial barrier.
Li MX; Li MY; Lei JX; Wu YZ; Li ZH; Chen LM; Zhou CL; Su JY; Huang GX; Huang XQ; Zheng XB
Phytomedicine; 2022 Jun; 100():154052. PubMed ID: 35344714
[TBL] [Abstract][Full Text] [Related]
19. Let-7b ameliorates Crohn's disease-associated adherent-invasive E coli induced intestinal inflammation via modulating Toll-Like Receptor 4 expression in intestinal epithelial cells.
Guo Z; Cai X; Guo X; Xu Y; Gong J; Li Y; Zhu W
Biochem Pharmacol; 2018 Oct; 156():196-203. PubMed ID: 30142321
[TBL] [Abstract][Full Text] [Related]
20. Olaparib: A Clinically Applied PARP Inhibitor Protects from Experimental Crohn's Disease and Maintains Barrier Integrity by Improving Bioenergetics through Rescuing Glycolysis in Colonic Epithelial Cells.
Kovács D; Vántus VB; Vámos E; Kálmán N; Schicho R; Gallyas F; Radnai B
Oxid Med Cell Longev; 2021; 2021():7308897. PubMed ID: 34567413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
